← Leaderboards
Jacob Lowell Glass
Sloan-Kettering Inst Can Research
$1,421,573
Attributed
$1,421,573
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300.8K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,421,573 · 1
By mechanism
K08$1,421,573 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Eirini Papapetrou$13,419,805
- Michael Kharas$18,485,709
- Craig B Thompson$56,520,903
- Ross L Levine$31,715,816
- Samuel Singer$8,089,401
Others in their field
Other Emerging Leaders on “Epigenetic Process”
- Michael-Christopher Keogh · Epicypher, Inc.$20,096,362
- Barbara Halina Braffett · George Washington University$9,972,097
- Ionut Bebu · George Washington University$9,972,097
- Jennifer Cohen Price · University Of California, San Francisco$9,197,178
- Scott Topper · Broad Institute, Inc.$8,965,812
- Ruchir Shah · Sciome, Llc$7,820,780
Research focus
Epigenetic ProcessAcute LeukemiaAcute Biphenotypic LeukemiaEnvironmentAdvisory CommitteesAllelesAcute Lymphocytic LeukemiaBioinformaticsAcuteEfficacy TestingBiologyCareerCellsCellular MorphologyCharacteristicsChemotherapyClinical DiagnosisDisorder SubtypeDna MethylationBiologicalAcute Myelocytic LeukemiaEffective TherapyEducational CurriculumEpigenetic Therapy
Grant awards (5)
Lineage identification and targeted therapeutics in acute leukemia$273,347
K08 · FY2023 · CA · contact PI
Lineage identification and targeted therapeutics in acute leukemia$273,347
K08 · FY2022 · CA · contact PI
Lineage identification and targeted therapeutics in acute leukemia$273,347
K08 · FY2021 · CA · contact PI
Lineage identification and targeted therapeutics in acute leukemia$300,766
K08 · FY2020 · CA · contact PI
Lineage identification and targeted therapeutics in acute leukemia$300,766
K08 · FY2019 · CA · contact PI